Value of stimulated pre-ablation thyroglobulin as a prognostic marker in patients with differentiated thyroid carcinoma treated with radioiodine

G Nóbrega, M Cavalcanti, V Leite, L Vilar… - Endocrine, 2022 - Springer
Abstract Objective To determine which Thyroglobulin (Tg) level after levothyroxine (LT4)
withdrawal (stimulated thyroglobulin-sTg) measured before radioiodine therapy (RAIT) is …

Value of stimulated pre-ablation thyroglobulin as a prognostic marker in patients with differentiated thyroid carcinoma treated with radioiodine.

G Nóbrega, M Cavalcanti, V Leite, L Vilar… - Endocrine …, 2022 - search.ebscohost.com
Abstract Objective: To determine which Thyroglobulin (Tg) level after levothyroxine (LT<
sub> 4</sub>) withdrawal (stimulated thyroglobulin-sTg) measured before radioiodine …

Value of stimulated pre-ablation thyroglobulin as a prognostic marker in patients with differentiated thyroid carcinoma treated with radioiodine

G Nóbrega, M Cavalcanti, V Leite, L Vilar… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective To determine which Thyroglobulin (Tg) level after levothyroxine (LT 4) withdrawal
(stimulated thyroglobulin-sTg) measured before radioiodine therapy (RAIT) is able to predict …

[引用][C] Value of stimulated pre-ablation thyroglobulin as a prognostic marker in patients with differentiated thyroid carcinoma treated with radioiodine

G Nóbrega, M Cavalcanti, V Leite, L Vilar… - Endocrine, 2022 - cir.nii.ac.jp
Value of stimulated pre-ablation thyroglobulin as a prognostic marker in patients with
differentiated thyroid carcinoma treated with radioiodine | CiNii Research CiNii 国立情報学 …

Value of stimulated pre-ablation thyroglobulin as a prognostic marker in patients with differentiated thyroid carcinoma treated with radioiodine.

G Nóbrega, M Cavalcanti, V Leite, L Vilar… - Endocrine, 2022 - europepmc.org
Objective To determine which Thyroglobulin (Tg) level after levothyroxine (LT 4) withdrawal
(stimulated thyroglobulin-sTg) measured before radioiodine therapy (RAIT) is able to predict …